Funding Rounds
IOmx Therapeutics

IOmx Therapeutics Series B (2021, $75M)

IOmx Therapeutics

Cancer treatment development focused on creating first-of-their-kind therapies.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $75.37M

Raised Date: 2021-01-01